Zenith Drugs Limited (NSE:ZENITHDRUG)

Zenith Drugs Revenue

In the fiscal year ending March 31, 2026, Zenith Drugs had annual revenue of 1.76B INR with 32.25% growth. Zenith Drugs had revenue of 782.24M in the half year ending September 30, 2025.

• Revenue: 1.76B
• Revenue Growth: +32.25%
• P/S Ratio: 0.41
• Revenue / Employee: 9.69M
• Employees: 182
• Market Cap: 714.25M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.76B	430.01M	32.25%
Mar 31, 2025	1.33B	17.00M	1.29%
Mar 31, 2024	1.32B	171.01M	14.93%
Mar 31, 2023	1.15B	228.64M	24.95%
Mar 31, 2022	916.55M	182.53M	24.87%

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 15, 2026

Data Sources Report a data error